SynCore BiotechnologyLtd Balance Sheet Health
Financial Health criteria checks 6/6
SynCore BiotechnologyLtd has a total shareholder equity of NT$312.0M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$331.8M and NT$19.8M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$217.54m |
| Equity | NT$311.95m |
| Total liabilities | NT$19.84m |
| Total assets | NT$331.79m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 4192's short term assets (NT$265.7M) exceed its short term liabilities (NT$17.4M).
Long Term Liabilities: 4192's short term assets (NT$265.7M) exceed its long term liabilities (NT$2.5M).
Debt to Equity History and Analysis
Debt Level: 4192 is debt free.
Reducing Debt: 4192 has no debt compared to 5 years ago when its debt to equity ratio was 4%.
Debt Coverage: 4192 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4192 has no debt, therefore coverage of interest payments is not a concern.